{"id":239379,"date":"2010-01-27T13:40:26","date_gmt":"2010-01-27T18:40:26","guid":{"rendered":"http:\/\/www.technologytransfertactics.com\/content\/?p=5781"},"modified":"2010-01-27T13:40:26","modified_gmt":"2010-01-27T18:40:26","slug":"royalty-rates-for-technology-medical-devices-and-diagnostics-edition-now-available","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/239379","title":{"rendered":"Royalty Rates for Technology: Medical Devices and Diagnostics Edition now available"},"content":{"rendered":"<p>In association with IPRA Inc. and its principal, royalty rate and                valuation expert Russell Parr, 2Market Information Inc. has created                a targeted reference by deriving all medical device and diagnostics                entries from the more comprehensive &#8212; and more costly &#8212; technology                edition of this unique benchmarking series. Why? So if your interest                is focused primarily on the medical device industry, you can access                this valuable data at a much lower price than the larger volume.                <strong> <em>Royalty Rates for Technology: Medical Devices and Diagnostics                Edition<\/em><\/strong> reports all available compensation terms from                scores of completed medical device license agreements, gathered                from more than 20 years of Mr. Parr\u2019s research. You\u2019ll                find details on fixed royalty rates, per unit royalties, scaled                royalty rates, and license fees. But you get more than just rates                and data &#8212; you get context as well. For each transaction you\u2019ll                find:<\/p>\n<ul>\n<li> A description of the licensed technology <\/li>\n<li>Compensation terms including royalty rates and license fees<\/li>\n<li> Identity of the licensor and licensee<\/li>\n<li> Transaction background and history<\/li>\n<li> Market analysis and benefits of the licensed technology<\/li>\n<\/ul>\n<p>This new edition is available for immediate download. For more                detail and to order, <a href=\"http:\/\/www.technologytransfertactics.com\/content\/ipra\/tech-med-en\/\">CLICK                HERE<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In association with IPRA Inc. and its principal, royalty rate and valuation expert Russell Parr, 2Market Information Inc. has created a targeted reference by deriving all medical device and diagnostics entries from the more comprehensive &#8212; and more costly &#8212; technology edition of this unique benchmarking series. Why? So if your interest is focused primarily [&hellip;]<\/p>\n","protected":false},"author":67,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-239379","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/239379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/67"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=239379"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/239379\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=239379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=239379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=239379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}